Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) EPS (Basic) (2016 - 2025)

Orthopediatrics has reported EPS (Basic) over the past 10 years, most recently at -$0.43 for Q4 2025.

  • Quarterly results put EPS (Basic) at -$0.43 for Q4 2025, up 38.57% from a year ago — trailing twelve months through Dec 2025 was -$1.69 (down 3.05% YoY), and the annual figure for FY2025 was -$1.69, down 3.05%.
  • EPS (Basic) for Q4 2025 was -$0.43 at Orthopediatrics, up from -$0.5 in the prior quarter.
  • Over the last five years, EPS (Basic) for KIDS hit a ceiling of $0.88 in Q3 2022 and a floor of -$0.7 in Q4 2024.
  • Median EPS (Basic) over the past 5 years was -$0.3 (2023), compared with a mean of -$0.25.
  • Peak annual rise in EPS (Basic) hit 900.0% in 2022, while the deepest fall reached 10269.36% in 2022.
  • Orthopediatrics' EPS (Basic) stood at $0.0 in 2021, then tumbled by 10269.36% to -$0.38 in 2022, then grew by 23.68% to -$0.29 in 2023, then crashed by 141.38% to -$0.7 in 2024, then soared by 38.57% to -$0.43 in 2025.
  • The last three reported values for EPS (Basic) were -$0.43 (Q4 2025), -$0.5 (Q3 2025), and -$0.3 (Q2 2025) per Business Quant data.